INVO Fertility, Inc. (NASDAQ: IVF) has announced a 1-for-5 reverse stock split of its common stock, effective at 12:01 a.m. Eastern Time on March 27, 2026. This decision was formalized through a Certificate of Change filed with the Secretary of State of Nevada on March 25, 2026. The reverse stock split will reduce the number of shares outstanding, consolidating every five shares into one share, while maintaining the par value of $0.0001 per share. Following the split, the company will have approximately 1,615,419 shares issued and outstanding and will adjust its authorized shares to 50,000,000. The common stock will continue to trade under the existing symbol 'IVF' on The Nasdaq Capital Market, but will be assigned a new CUSIP number (44984F880). This strategic move is aimed at enhancing the company's marketability and potentially improving its stock price, which has been under pressure. The company also issued a press release on the same day to inform stakeholders about the reverse stock split, emphasizing its commitment to enhancing shareholder value. The reverse stock split is expected to have a positive impact on the stock price by reducing the number of shares available in the market, which could lead to a higher price per share. However, it is important to note that reverse stock splits do not inherently create value; they merely adjust the share price and can sometimes be viewed negatively by investors. The company continues to focus on expanding its fertility services and technologies, which may contribute to long-term growth and stability.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.